Your browser doesn't support javascript.
loading
Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy.
Costa Svedman, Fernanda; Jalsenius, Marie; Grozman, Vitali; Bergqvist, Mattias; Söderdahl, Fabian; Rotstein, Samuel; Ny, Lars; Egyhazi Brage, Suzanne; Helgadottir, Hildur.
Afiliação
  • Costa Svedman F; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Jalsenius M; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Grozman V; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Bergqvist M; Section of Thoracic Radiology, Department of Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden.
  • Söderdahl F; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Rotstein S; Biovica International AB, Uppsala Science Park, Uppsala, Sweden.
  • Ny L; Statisticon AB, Uppsala, Sweden.
  • Egyhazi Brage S; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Helgadottir H; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Acta Oncol ; 61(9): 1116-1120, 2022 09.
Article em En | MEDLINE | ID: mdl-36083107

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Humans Idioma: En Revista: Acta Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Humans Idioma: En Revista: Acta Oncol Ano de publicação: 2022 Tipo de documento: Article